| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.02▼ | 2.03▼ | 2.02▼ | 1.89▲ | 2.00▼ |
| MA10 | 2.02▼ | 2.03▼ | 2.00▼ | 1.90▲ | 1.67▲ |
| MA20 | 2.03▼ | 2.00▼ | 1.95▲ | 2.04▼ | 1.29▲ |
| MA50 | 2.03▼ | 1.89▲ | 1.84▲ | 1.66▲ | 1.54▲ |
| MA100 | 2.00▼ | 1.84▲ | 1.93▲ | 1.28▲ | 2.90▼ |
| MA200 | 1.93▲ | 1.95▲ | 1.95▲ | 1.47▲ | 5.87▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | -0.007▼ | 0.004▲ | -0.034▼ | 0.128▲ |
| RSI | 32.431▼ | 51.110▲ | 57.212▲ | 54.746▲ | 59.789▲ |
| STOCH | 61.409 | 54.648 | 65.925 | 40.659 | 69.055 |
| WILL %R | -85.714▼ | -77.778▼ | -42.857 | -44.636 | -35.962 |
| CCI | -228.571▼ | -131.180▼ | 30.764 | 49.388 | 70.510 |
|
Tuesday, August 12, 2025 01:18 PM
Two robust clinical datasets from CB-010 and CB-011 expected to be disclosed in H2 2025 -- -- $184 million in cash, cash equivalents, and marketable securities expected to fund the Company’s current ...
|
|
Thursday, July 17, 2025 11:31 AM
Topline Summary Caribou Biosciences, Inc. (NASDAQ: CRBU) is a cell therapy-focused biotech working to commercialize gene-edited, allogeneic CAR T-cell treatments for different forms of blood cancer.
|
|
Friday, March 10, 2023 12:39 PM
NEW YORK, March 10, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the stock of Caribou Biosciences, Inc. (NASDAQ: CRBU): (i) pursuant and ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 2.00 | 2.09 | 1.95 | 1.98 | 1,109,039 |
| 14/08/25 | 1.92 | 2.02 | 1.83 | 2.00 | 1,277,781 |
| 13/08/25 | 1.72 | 1.95 | 1.6203 | 1.95 | 1,490,409 |
| 12/08/25 | 1.71 | 1.79 | 1.705 | 1.79 | 714,535 |
| 11/08/25 | 1.70 | 1.77 | 1.68 | 1.71 | 644,516 |
| 08/08/25 | 1.86 | 1.87 | 1.715 | 1.73 | 658,698 |
| 07/08/25 | 1.89 | 1.92 | 1.79 | 1.81 | 1,143,020 |
| 06/08/25 | 2.05 | 2.05 | 1.85 | 1.88 | 1,426,409 |
| 05/08/25 | 2.11 | 2.11 | 1.995 | 2.04 | 1,176,490 |
| 04/08/25 | 2.045 | 2.13 | 1.9406 | 2.10 | 992,278 |
|
|
||||
|
|
||||
|
|